#23-02 Rights issue in Coegin Pharma AB
Following an authorization from the annual general meeting, held on May 19, 2022, the board of Coegin Pharma AB (“the Company”) has decided on a rights issue with preferential rights for the Company’s existing shareholders.
The last day of trading in the Company’s shares including the right to receive subscription rights is January 11, 2023. The first day of trading in the Company’s shares excluding the right to receive subscription rights is January 12, 2023. The record date is January 13, 2023.
The shareholders of the Company will receive one (1) subscription right for each share held per the record date. Five (5) subscription rights are required to subscribe to one (1) new share. The subscription price is 0.11 SEK per share.
Subscription of shares will take place from and including January 17, 2023 to and including January 31, 2023. Trading in subscription rights will take place on NGM from and including January 17, 2023 to and including January 26, 2023.
Trading in paid subscription shares will take place on NGM from and including January 17, 2023 until the rights issue is registered with the Swedish Companies Registration Office.
If the rights issue results in an adjustment factor, orders in the Company’s order book will deleted after the end of the trading day on January 11, 2023.
Information regarding the affected instruments:
Listing name: Coegin Pharma TR
Exchange symbol: COEGIN TR
ISIN-code: SE0019354796
CFI-code: RSSXXR
FISN-code: COEGINPHAR/SUBS RTS NL PD
First day of trading: 2023-01-17
Last day of trading: 2023-01-26
Instrument-ID: BVYH
Tick size table/liquidity band: A
Number of issued instruments: 694 292 035
Market-ID: NSME
Segment-ID: NSSE
Listing name: Coegin Pharma BT
Exchange symbol: COEGIN BT
ISIN-code: SE0019354804
CFI-code: ESNUFR
FISN-code: COEGINPHAR/SH
First day of trading: 2023-01-17
Last day of trading: Will be announced later in a separate Market Notice
Instrument-ID: BVYG
Tick size table/liquidity band: A
Number of issued instruments: 138 858 407
Market-ID: NSME
Segment-ID: NSSE
For more information about this Market Notice, please contact us by e-mail, marketsurveillance@ngm.se or telephone, +46 8 566 390 55.
NGM Market Notice Pressroom